| Literature DB >> 28740944 |
Éric Heleno Freire Ferreira Frederico1,2, Danúbia da Cunha de Sá-Caputo1,3, Eloá Moreira-Marconi1,3, Carlos Alberto Sampaio Guimarães1, André Luiz Bandeira Dionísio Cardoso1,4, Carla da Fontoura Dionello1,4, Danielle Soares Morel1,4, Cintia Renata Sousa-Gonçalves1,4, Laisa Liana Paineiras-Domingos1,4, Rebeca Graça Costa Cavalcanti1,5, Nasser Ribeiro Asad1, Pedro Jesus Marin6, Mario Bernardo-Filho1.
Abstract
BACKGROUND: Whole body vibration (WBV) exercise has been used in health sciences. Authors have reported that changes on the concentration of plasma biomarkers could be associated with the WBV effects. The aim of this investigation is to assess the consequences of exposition of 25 Hz mechanical vibration generated in oscillating/vibratory platform (OVP) on the concentration of some plasma biomarkers and on the weight of rats.Entities:
Keywords: mechanical vibration; plasma biomarkers; weight; whole body vibration
Mesh:
Substances:
Year: 2017 PMID: 28740944 PMCID: PMC5514439 DOI: 10.21010/ajtcam.v14i4S.7
Source DB: PubMed Journal: Afr J Tradit Complement Altern Med ISSN: 2505-0044
Thehe CG and EG before and after the procedure involving WBV exercise with vibration of 25 Hz
| Groups | Weight before (g) | Weight after (g) | ||
|---|---|---|---|---|
| CG | 230.0±19.4 | 251.6±19.3 | 0.0409 | 1.11 |
| EG | 223.3±22.8 | 240.7±23.1 | 0.1103 | 0.75 |
CG – Control group, EG – Experimental group, p – level of significance,
statistical difference (p<0.05), d-value - Cohen’s effect sizes, d ≤ 0.2 was considered a small effect sizes, 0.2< d < moderate effect sizes and d ≥ 0.8 large effects sizes. The weight of the animals was determined before and after the WBV exercises.
Concentration of some biomarkers determined in animals submitted to the 25 Hz vibration generated in oscillating platform.
| Biomarkers | CG Mean ± SD | EG Mean ± SD | ||
|---|---|---|---|---|
| Glucose (mg/dL) | 149.3±50.4 | 125.6 ±20.5 | 0.42 | 0.61 |
| Creatinine(mg/dL) | 0.66±1.04 | 0.24±0.05 | 0.32 | 0.57 |
| Cholesterol (mg/dL) | 54.16±9.45 | 55.6±4.39 | 0.5 | 0.19 |
| Triglyceride (mg/dL) | 48.16±18.61 | 34.6±13.83 | 0.13 | 0.82 |
| HDL (mg/dL) | 43.66±7.14 | 45.14 ±3.84 | 0.29 | 0.25 |
| Alkaline Phosphatase (U/L) | 183±16.80 | 165±24.89 | 0.13 | 0.84 |
| Bilirubin (mg/dL) | 0.05±0.02 | 0.05±0.01 | 0.35 | 0.00 |
| Amylase (U/L) | 2979±594.68 | 2360.8±234.83 | 0.03 | 1.36 |
| Lipase (U/L) | 7.13±0.57 | 7.18±0.54 | 0.29 | 0.09 |
| CK (U/L) | 3456.1±4436.7 | 3710.4±5448.4 | 0.42 | 0.08 |
| Calcium (mg/dL) | 10.95 ±0.88 | 10.02±0.68 | 0.051 | 1.18 |
| Magnesium (mg/dL) | 3.08±0.76 | 2.78±0.30 | 0.29 | 0.51 |
| Total Protein(mg/dL) | 5.58±0.52 | 5.4±0.25 | 0.23 | 0.44 |
| Albumin (mg/dL) | 3.65±0.27 | 3.56±0.05 | 0.13 | 0.46 |
CG – Control group, EG – Experimental group, p – level of significance,
statistical difference (p<0.05), d-value - Cohen’s effect sizes, d ≤ 0.2 was considered a small effect sizes, 0.2< d < moderate effect sizes and d ≥ 0.8 large effects sizes. The weight of the animals was determined before and after the WBV exercises.